TEACH: Trial of Education And Compliance in Heart dysfunction chronic disease and heart failure (HF) as an increasing problem

Contemporary Clinical Trials

Volumn 29, Issue 6, 2008, Pages 905-918

  Gwadry Sridhar, Femida ^a,b   Guyatt, Gordon ^b   O'Brien, Bernie ^e   Arnold, J Malcom ^c   Walter, Stephen ^b   Vingilis, Evelyn ^a   MacKeigan, Linda ^d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e NONE

Author keywords

Compliance; Educational interventions; Heart failure

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMERGENCY CARE; HEALTH EDUCATION; HEART FAILURE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTERVENTION STUDY; MEDICAL RESEARCH; MORTALITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION;

DATABASES AS TOPIC; EDUCATIONAL MEASUREMENT; HEART DISEASES; HEART FAILURE; HUMANS; MEDICATION ADHERENCE; MODELS, EDUCATIONAL; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; PATIENT READMISSION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE;

EID: 53649109243     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2008.07.001     Document Type: Article

References (102)

1. Brogan Report. Utilization of resources for hypertension and heart failure. Merck Frosst Canada (1996)
2. O'Connell M.B., and Johnson J.F. Evaluation of medication knowledge in elderly patients. Ann Pharmacother 26 7-8 (Jul 1992) 919-921
3. Monane M., Bohn R.L., Gurwitz J.H., Glynn R.J., and Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 154 4 (Feb 28 1994) 433-437
4. Dracup K., Baker D.W., Dunbar S.B., et al. Management of heart failure. II. Counseling, education, and lifestyle modifications. JAMA 272 18 (Nov 9 1994) 1442-1446
5. Sullivan M.J., and Hawthorne M.H. Nonpharmacologic interventions in the treatment of heart failure. J Cardiovasc Nurs 10 2 (Jan 1996) 47-57
6. Wolinsky F.D., Overhage J.M., Stump T.E., Lubitz R.M., and Smith D.M. The risk of hospitalization for congestive heart failure among older adults. Med Care 35 10 (Oct 1997) 1031-1043
7. Ghali J.K., Cooper R., and Ford E. Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence. Arch Intern Med 150 4 (Apr 1990) 769-773
8. Falotico-Taylor J., McClellan M., and Mosteller F. The use of quality of life measures in technology assessment. In: Mosteller F., and Falotico-Taylor J. (Eds). Quality of life and technology assessment: monograph of the Council on Health Care Technology (1989), National Academy Press, Washington, D.C. 7-44
9. Kannel W.B., and Belanger A.J. Epidemiology of heart failure. Am Heart J 121 3 Pt 1 (Mar 1991) 951-957
10. Rich M.W. Multidisciplinary interventions for the management of heart failure: where do we stand?. Am Heart J 138 4 Pt 1 (Oct 1999) 599-601
11. Haldeman G.A., Croft J.B., Giles W.H., and Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 137 2 (Feb 1999) 352-360
12. Cline C.M., Israelsson B.Y., Willenheimer R.B., Broms K., and Erhardt L.R. Cost effective management programme for heart failure reduces hospitalisation. Heart 80 5 (Nov 1998) 442-446
13. Heidenreich P.A., Ruggerio C.M., and Massie B.M. Effect of a home monitoring system on hospitalization and resource use for patients with heart failure. Am Heart J 138 4 Pt 1 (Oct 1999) 633-640
14. Garg R., and Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative group on ACE inhibitor trials. JAMA 273 18 (May 10 1995) 1450-1456
15. Hjalmarson A., Goldstein S., Fagerberg B., et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF study group. JAMA 283 10 (Mar 8 2000) 1295-1302
16. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 9169 (Jun 12 1999) 2001-2007
17. Goldstein S. Clinical studies on beta blockers and heart failure preceding the MERIT-HF Trial. Metoprolol CR/XL Randomized Intervention Trial in Heart Failure. Am J Cardiol 80 9B (Nov 13 1997) 50J-53J
18. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 10 (Sep 2 1999) 709-717
19. Julian D.G., Camm A.J., Frangin G., et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 349 9053 (Mar 8 1997) 667-674
20. Garguichevich J.J., Ramos J.L., Gambarte A., et al. Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA). Am Heart J 130 3 Pt 1 (Sep 1995) 494-500
21. Krumholz H.M., Chen Y.T., Wang Y., et al. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J 139 1 Pt 1 (Jan 2000) 72-77
22. Fallen E.L., Cairns J., Dafoe W., et al. Management of the postmyocardial infarction patient: a consensus report - revision of 1991 CCS guidelines. Can J Cardiol 11 6 (Jun 1995) 477-486
23. The Agency for Health Care Policy and Research. AHCPR Clinical Practice Guidelines (1994)
24. Block L., Fredericks L.A., and Moore B. The design and implementation of a disease management program for congestive heart failure at a community hospital. Congest Heart Fail 4 4 (1997) 22-37
25. Edep M.E., Shah N.B., Tateo I.M., and Massie B.M. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol 30 2 (Aug 1997) 518-526
26. Hanumanthu S., Butler J., Chomsky D., Davis S., and Wilson J.R. Effect of a heart failure program on hospitalization frequency and exercise tolerance. Circulation 96 9 (Nov 4 1997) 2842-2848
27. Reis S.E., Holubkov R., Edmundowicz D., et al. Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes. J Am Coll Cardiol 30 3 (Sep 1997) 733-738
28. Fonarow G.C., Stevenson L.W., Walden J.A., et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 30 3 (Sep 1997) 725-732
29. Raval A.N., Marchiori G.E., and Arnold J.M. Improving the continuity of care following discharge of patients hospitalized with heart failure: is the discharge summary adequate?. Can J Cardiol 19 4 (Mar 31 2003) 365-370
30. Miller N.H. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med 102 2A (Feb 17 1997) 43-49
31. Montague T. Merck Frosst Pharmaceutical Report for the British Pharmaceutical Society on Medication Compliance (1997)
32. IMPPACC TF Group. Presentation by Merck Frosst on medication compliance. Waltham, MA: Presented at AHA Compliance Meeting; 1999 Apr.
33. Haynes R.B. A critical review of the 'determinants' of patient compliance with therapeutic regimens. In: Sackett D.L., and Haynes R.B. (Eds). Compliance with Therapeutic Regimens (1979), Johns Hopkins University Press, Baltimore, MD 11-22
34. Compliance in Healthcare and Research (2001), American Heart Association, Futura Publishing Co., Inc., New York
35. Cramer J.A., Roy A., Burrell A., et al. Medication compliance and persistence: terminology and definitions. Value Health 11 1 (2008) 44-47
36. Stewart R.B., and Caranasos G.J. Medication compliance in the elderly. Med Clin North Am 73 6 (Nov 1989) 1551-1563
37. Hogarty J.S. Reactance theory and patient noncompliance. Soc Sci Med 45 8 (1997) 1277-1288
38. Coambs R.B. Review of the Scientific Literature on the Prevalence, Consequences, and Health Costs of Noncompliance and Inappropriate Use of Presription Costs of Medication in Canada (1995), University of Toronto Press, Toronto
39. Lash S., and Harding J. "Abandoned prescriptions" a quantitative assessment of their cause. J Manag Care Pharm 1 (1995) 193-199
40. West J.A., Miller N.H., Parker K.M., et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol 79 1 (Jan 1 1997) 58-63
41. Ghali J.K., Kadakia S., Cooper R., and Ferlinz J. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med 148 9 (Sep 1988) 2013-2016
42. Funk M., and Krumholz H.M. Epidemiologic and economic impact of advanced heart failure. J Cardiovasc Nurs 10 2 (Jan 1996) 1-10
43. Michalsen A., Konig G., and Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 80 5 (Nov 1998) 437-441
44. O'Connell J.B. The economic burden of heart failure. Clin Cardiol 23 3 Suppl (Mar 2000) III6-III10
45. Miller N.H., Hill M., Kottke T., and Ockene I.S. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 95 4 (Feb 18 1997) 1085-1090
46. McDermott M.M., Schmitt B., and Wallner E. Impact of medication nonadherence on coronary heart disease outcomes. A critical review. Arch Intern Med 157 17 (Sep 22 1997) 1921-1929
47. Hagenhoff B.D., Feutz C., Conn V.S., Sagehorn K.K., and Moranville-Hunziker M. Patient education needs as reported by congestive heart failure patients and their nurses. J Adv Nurs 19 4 (Apr 1994) 685-690
48. Rich M.W. Multidisciplinary interventions for the management of heart failure: where do we stand?. Am Heart J 138 4 Pt 1 (Oct 1999) 599-601
49. Rich M.W. Non-pharmacological treatment of heart failure: just as important?. In: McMurray J.J., and Cleleand J.G.F. (Eds). Heart failure in clinical practice. 2nd ed. (2003), Martin-Dunitz, Ltd., London 321-335
50. Harrison M.B., Toman C., and Logan J. Hospital to home evidence-based education for CHF. Can Nurse 94 2 (Feb 1998) 36-42
51. Rich M.W., Beckham V., Wittenberg C., et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333 18 (Nov 2 1995) 1190-1195
52. Rich M.W. Multidisciplinary interventions for the management of heart failure: where do we stand?. Am Heart J 138 4 Pt 1 (Oct 1999) 599-601
53. Rich M.W. Non-pharmacological treatment of heart failure: just as important?. In: McMurray J.J., and Cleleand J.G.F. (Eds). Heart failure in clinical practice. 2nd ed. (2003), Martin-Dunitz, Ltd., London 321-335
54. Dunbar S.B., Jacobson L.H., and Deaton C. Heart failure: strategies to enhance patient self-management. AACN Clin Issues 9 2 (May 1998) 244-256
55. Opdycke R.A., Ascione F.J., Shimp L.A., and Rosen R.I. A systematic approach to educating elderly patients about their medications. Patient Educ Couns 19 1 (Feb 1992) 43-60
56. Schulz R.M., and Gagnon J.P. Patient behavior patterns regarding prescription refills. Contemp Pharm Pract 5 3 (1982) 150-155
57. Smith M. Medication, quality of life and compliance: the role of the pharmacist. Pharmacoeconomics 1 4 (Apr 1992) 225-230
58. Bero L.A., Mays N.B., Barjesteh K., and Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev 2 (2000) CD000336
59. Bogden P.E., Abbott R.D., Williamson P., Onopa J.K., and Koontz L.M. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med 13 11 (Nov 1998) 740-745
60. Gottlieb H. Medication nonadherence: finding solutions to a costly medical problem. Drug Benefit Trends 12 (2000) 57-62
61. Rossi P.H., and Freeman H.E. Evaluation: A systematic Approach. 5 ed. (1993), Sage, Newbury, CA
62. Rossi P.H., and Freeman H.E. Evaluation: A systematic approach. 6 ed. (1999), Sage Publications, Newbury Park, NJ
63. Bernstein I.N., and Sheldon E.B. Evaluative research. In: Smith R.B. (Ed). Handbook of Social Science Methods (1983), Ballinger Publications, Cambridge, MA
64. Isaac S., and Michael W.B. Handbook in Research and Evaluation. 3rd ed. (1997), EdITS/Educational and Industrial Testing Services, San Diego, CA
65. Posovac E.J., and Carey R.G. Program Evaluation: Methods and Case Studies. 5 ed. (1997), Upper Saddle, NJ, Prentice-Hall
66. Chen H. Theory-driven Evaluations (1990), Newbury Park, CA, Sage Publications
67. Lipsey M.W., and Pollard J.A. Driving toward theory in program evaluation. Eval Program Plann 12 (1989) 317-328
68. Chen H., and Rossi P.H. Issues in the theory-driven perspective. Eval Program Plan 12 (1989) 299-306
69. Thompson N.J., and McClintock H.O. Demonstrating your program's worth: a primer on evaluation for programs to prevent unintentional injury (1998), National Centre for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA
70. Lipsey M.W. Practice and malpractice in evaluation research. Eval Pract 9 (1988) 5-24
71. Chen H. The conceptual framework of the theory-driven perspective. Eval Program Plann 12 (1989) 391-396
72. Chen H., and Rossi P.H. The multi-goal, theory-driven approach to evaluation: a model for linking basic and applied social science. Soc Forces 59 (1989) 106-122
73. Sidani S., and Braden C.J. Evaluating nursing interventions: a theory driven approach (1998), Sage Publications, Thousand Oaks, CA
74. Vingilis E., Brown U., Koeppen R., et al. Evaluation of a cold/flu self-care public education campaign. Health Educ Res 13 1 (Mar 1998) 33-46
75. Arnold J.M., Liu P., Demers C., et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 22 1 (Jan 2006) 23-45
76. Gwadry-Sridhar F.H., Arnold J.M., Zhang Y., et al. Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. Am Heart J 150 5 (Nov 2005) 982
77. Gwadry-Sridhar F., Guyatt G.H., Arnold J.M., et al. Instruments to measure acceptability of information and acquisition of knowledge in patients with heart failure. Eur J Heart Fail 5 6 (Dec 2003) 783-791
78. Tones B.K. The use and abuse of mass media in health promotion. Health Educ Res (1985) 9-14 Pilot Issue
79. Vingilis E., Brown U., Koeppen R., et al. Evaluation of a cold/flu self-care public education campaign. Health Educ Res 13 1 (Mar 1998) 33-46
80. Monane M., Bohn R.L., Gurwitz J.H., et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 10 7 Pt 1 (Jul 1997) 697-704
81. Haldeman G.A., Croft J.B., Giles W.H., and Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 137 2 (Feb 1999) 352-360
82. Arnold J.M. Felodipine in addition to enalapril did not improve clinical status, functional capacity or ventricular function in patients with CHF. Evid Based Cardiovasc Med 2 1 (Mar 1998) 18
83. Steiner J.F., and Prochazka A.V. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 50 1 (Jan 1997) 105-116
84. Cramer J.A., Mattson R.H., Prevey M.L., Scheyer R.D., and Ouellette V.L. How often is medication taken as prescribed? A novel assessment technique. JAMA 261 22 (Jun 9 1989) 3273-3277
85. Wolinsky F.D., Wyrwich K.W., Nienaber N.A., and Tierney W.M. Generic versus disease-specific health status measures. An example using coronary artery disease and congestive heart failure patients. Eval Health Prof 21 2 (Jun 1998) 216-243
86. Feeny D.H., Torrance G.W., and Furlong W.J. Health Utilities Index. In: Spilker B. (Ed). Quality of life and pharmacoeconomics in clinical trials. 2 ed. (1996), Lippincott-Raven, Philadelphia, PA 239-251
87. Spilker B. Quality of life assessments in clinical trials (1990), New York, NY, Raven Press
88. Wolinsky F.D., Wyrwich K.W., Nienaber N.A., and Tierney W.M. Generic versus disease-specific health status measures. An example using coronary artery disease and congestive heart failure patients. Eval Health Prof 21 2 (Jun 1998) 216-243
89. Wolinsky F.D., Wyrwich K.W., Nienaber N.A., and Tierney W.M. Generic versus disease-specific health status measures. An example using coronary artery disease and congestive heart failure patients. Eval Health Prof 21 2 (Jun 1998) 216-243
90. Drummond M.F., O'Brien B., Stoddart G.L., et al. Methods for the economic evaluation of health care programmes. 2 ed. (1997), Oxford University Press, Oxford (England)
91. Bleichrodt H. Health utility indices and equity considerations. J Health Econ 16 1 (Feb 1997) 65-91
92. Furlong W.J., Feeny D.H., Torrance G.W., et al. Position paper of use of Health Utilities Indices (HUI III) for the Centre of Health Economics (CHEPA) (1998), McMaster University, Hamilton, ON
93. Staquet J.J., Hays R.D., and Fayers P.M. Quality of life assessment in clinical trials. Methods and pratice (1998), Oxford University Press, Oxford (England)
94. Lee E.T. Statistical methods for survival data anlaysis. 2 ed. (1992), Wiley, New York
95. Donner A., Birkett N., and Buck C. Randomization by cluster. Sample size requirements and analysis. Am J Epidemiol 114 6 (Dec 1981) 906-914
96. Donner A. An empirical study of cluster randomization. Int J Epidemiol 11 3 (Sep 1982) 283-286
97. Monane M., Bohn R.L., Gurwitz J.H., et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 10 7 Pt 1 (Jul 1997) 697-704
98. Friedman L.M., Furberg C.D., and DeMets D.L. Fundamentals of clinical trials (1998), Spinger-Verlag, New York, NY
99. Norman G.R., Sridhar F.G., Guyatt G.H., and Walter S.D. Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care 39 10 (Oct 2001) 1039-1047
100. Bittner V. Determining prognosis in congestive heart failure: role of the 6-minute walk test. Am Heart J 138 4 Pt 1 (Oct 1999) 593-596
101. Rothman K., and Greenland S. Modern epidemiology. 2 ed. (1998), Lippincott-Raven, Philadelphia, PA
102. Campbell M., Fitzpatrick R., Haines A., et al. Framework for design and evaluation of complex interventions to improve health. BMJ 321 7262 (Sep 16 2000) 694-696